Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Effect of concomitant administration of trospium chloride extended release on the steady-state pharmacokinetics of metformin in healthy adults.

Oefelein MG, Tong W, Kerr S, Bhasi K, Patel RK, Yu D.

Clin Drug Investig. 2013 Feb;33(2):123-31. doi: 10.1007/s40261-012-0049-6.

PMID:
23325481
[PubMed - indexed for MEDLINE]
2.

Study of the population pharmacokinetic characteristics of once-daily trospium chloride 60 mg extended-release capsules in patients with overactive bladder and in healthy subjects.

Harnett MD, Shipley J, MacLean L, Schwiderski U, Sandage BW Jr.

Clin Drug Investig. 2013 Feb;33(2):133-41. doi: 10.1007/s40261-012-0039-8.

PMID:
23203138
[PubMed - indexed for MEDLINE]
3.

Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult subjects.

Boulton DW, Smith CH, Li L, Huang J, Tang A, LaCreta FP.

Clin Drug Investig. 2011;31(9):619-30. doi: 10.2165/11590290-000000000-00000.

PMID:
21819160
[PubMed - indexed for MEDLINE]
4.

Steady-state pharmacokinetics of a novel extended-release metformin formulation.

Timmins P, Donahue S, Meeker J, Marathe P.

Clin Pharmacokinet. 2005;44(7):721-9.

PMID:
15966755
[PubMed - indexed for MEDLINE]
5.

[Trospium chloride once daily for overactive bladder syndrome: results of a multicenter observational study].

Notz HJ, Hautumm B, Werdier D, Groves R, Odenthal KP.

Urologe A. 2013 Jan;52(1):65-70. doi: 10.1007/s00120-012-2989-0. German.

PMID:
23052979
[PubMed - indexed for MEDLINE]
6.

Pharmacokinetics of once-daily trospium chloride 60 mg extended release and twice-daily trospium chloride 20 mg in healthy adults.

Silver N, Sandage B, Sabounjian L, Schwiderski U, Shipley J, Harnett M.

J Clin Pharmacol. 2010 Feb;50(2):143-50. doi: 10.1177/0091270009345498. Epub 2009 Nov 30.

PMID:
19948948
[PubMed - indexed for MEDLINE]
7.

Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trials.

Sand PK, Rovner ES, Watanabe JH, Oefelein MG.

Drugs Aging. 2011 Feb 1;28(2):151-60. doi: 10.2165/11586740-000000000-00000.

PMID:
21275440
[PubMed - indexed for MEDLINE]
8.

Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials.

Staskin DR, Rosenberg MT, Sand PK, Zinner NR, Dmochowski RR.

Int J Clin Pract. 2009 Dec;63(12):1715-23. doi: 10.1111/j.1742-1241.2009.02189.x.

PMID:
19930332
[PubMed - indexed for MEDLINE]
9.

Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.

Herman GA, Bergman A, Yi B, Kipnes M; Sitagliptin Study 012 Group.

Curr Med Res Opin. 2006 Oct;22(10):1939-47.

PMID:
17022853
[PubMed - indexed for MEDLINE]
10.

Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms.

Zinner NR, Dmochowski RR, Staskin DR, Siami PF, Sand PK, Oefelein MG.

Neurourol Urodyn. 2011 Sep;30(7):1214-9. doi: 10.1002/nau.21000. Epub 2011 Apr 1.

PMID:
21462240
[PubMed - indexed for MEDLINE]
11.

Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged ≥ 75 years) with overactive bladder syndrome.

Sand PK, Johnson Ii TM, Rovner ES, Ellsworth PI, Oefelein MG, Staskin DR.

BJU Int. 2011 Feb;107(4):612-20. doi: 10.1111/j.1464-410X.2010.09519.x. Epub 2010 Aug 12.

PMID:
20707790
[PubMed - indexed for MEDLINE]
12.

Pharmacokinetics of a fixed-dose combination of atorvastatin and metformin extended release versus concurrent administration of individual formulations: a randomized, open-label, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study.

Kandhwal K, Dey S, Nazarudheen S, Arora R, Reyar S, Thudi NR, Monif T, Singh MK, Rao S.

Clin Drug Investig. 2011 Dec 1;31(12):853-63. doi: 10.2165/11592920-000000000-00000.

PMID:
21919543
[PubMed - indexed for MEDLINE]
13.

Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients.

Li J, Klemm K, O'Farrell AM, Guler HP, Cherrington JM, Schwartz S, Boyea T.

Curr Med Res Opin. 2010 Aug;26(8):2003-10. doi: 10.1185/03007995.2010.491266.

PMID:
20583949
[PubMed - indexed for MEDLINE]
14.

Pharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects.

Karim A, Covington P, Christopher R, Davenport M, Fleck P, Li X, Wann E, Mekki Q.

Int J Clin Pharmacol Ther. 2010 Jan;48(1):46-58.

PMID:
20040339
[PubMed - indexed for MEDLINE]
15.

Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials.

Ginsberg DA, Oefelein MG, Ellsworth PI.

Neurourol Urodyn. 2011 Apr;30(4):563-7. doi: 10.1002/nau.21018. Epub 2011 Jan 25.

PMID:
21268101
[PubMed - indexed for MEDLINE]
16.

Safety and efficacy of once-daily trospium chloride extended-release in male patients with overactive bladder.

MacDiarmid SA, Ellsworth PI, Ginsberg DA, Oefelein MG, Sussman DO.

Urology. 2011 Jan;77(1):24-9. doi: 10.1016/j.urology.2010.07.469. Epub 2010 Oct 23.

PMID:
20970833
[PubMed - indexed for MEDLINE]
17.

Trospium chloride treatment of overactive bladder.

Biastre K, Burnakis T.

Ann Pharmacother. 2009 Feb;43(2):283-95. doi: 10.1345/aph.1L160. Epub 2009 Feb 3. Review.

PMID:
19193592
[PubMed - indexed for MEDLINE]
18.

Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.

Kim BH, Shin KH, Kim J, Lim KS, Kim KP, Kim JR, Cho JY, Shin SG, Jang IJ, Yu KS.

Clin Ther. 2009 Nov;31(11):2755-64. doi: 10.1016/j.clinthera.2009.11.001.

PMID:
20110017
[PubMed - indexed for MEDLINE]
19.

Clinical pharmacokinetics of trospium chloride.

Doroshyenko O, Jetter A, Odenthal KP, Fuhr U.

Clin Pharmacokinet. 2005;44(7):701-20. Review.

PMID:
15966754
[PubMed - indexed for MEDLINE]
20.

Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies.

Vakily M, Lee RD, Wu J, Gunawardhana L, Mulford D.

Clin Drug Investig. 2009;29(1):35-50. doi: 10.2165/0044011-200929010-00004.

PMID:
19067473
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk